欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
HU/H/0896/002
药品名称
Leuprorelin HEXAL 5 mg
活性成分
Leuprorelin 5.0 mg
剂型
Implant
上市许可持有人
HEXAL AG Industriestr. 25 83607 Holzkirchen Germany
参考成员国 - 产品名称
Hungary (HU)
互认成员国 - 产品名称
Slovakia (SK)
Germany (DE)
Denmark (DK)
Ireland (IE)
Austria (AT)
Leuprorelin Sandoz 5 mg - Implantat für 3 Monate
Italy (IT)
Greece (GR)
Sweden (SE)
Leuprorelin Regiomedica
Norway (NO)
Poland (PL)
Leuprostin
许可日期
2009/07/08
最近更新日期
2025/01/24
药物ATC编码
L02AE02 leuprorelin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
04_DE1681_1_2_MR_Leuprorelin Regiomedica_final PAR
Date of last change:2024/09/06
Final Labelling
|
1_3_1 spc_label_pl _ common_outer _ 5_404
Date of last change:2024/09/06
Final PL
|
1_3_1 spc_label_pl _ common_pl _ 11_024
Date of last change:2024/09/06
Final SPC
|
1_3_1 spc_label_pl _ common_spc _ 10_469
Date of last change:2024/09/06
Final Product Information
|
common_final_pl_1681_001__V036
Date of last change:2024/09/06
Final Product Information
|
common_final_pl_1681_002__V036
Date of last change:2024/09/06
Final Product Information
|
common_final_spc_1681_001__V036
Date of last change:2024/09/06
Final Product Information
|
common_final_spc_1681_002__V036
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase